Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| UCB Pharma | INDUSTRY |
The long-term goal of this research is to improve seizure control among patients with epilepsy, which has the potential to improve quality of life for thousands of people living with epilepsy and reduce health care utilization, social and economic costs, and epilepsy-related mortalities. Participants who are suffering from epilepsy will be randomized to receive usual care (UC), a smartphone-based self-management intervention called Management of Risks in Epilepsy (MORE), or MORE + telephone-based motivational interviewing (MI). Participants will be followed for 3 months.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Usual Treatment | Experimental |
| |
| MORE | Experimental |
| |
| MORE + MI | Active Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Usual Care | Other | Participants assigned to this treatment will receive the usual care as determined by their physician |
|
| Measure | Description | Time Frame |
|---|---|---|
| Percent adherence to anti-epileptic drug schedule (pill counts) | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of patients who complete the study | 3 months | |
| Percentage of MI sessions completed | 3 months | |
| Percentage of diary entries completed |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Tanya Spruill | New York University Medical School | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| New York University School of Medicine | New York | New York | 10016 | United States |
Not provided
| ID | Term |
|---|---|
| D004827 | Epilepsy |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Management of Risks in Epilepsy (MORE) | Behavioral | MORE is a smartphone application which participants use to record information on a daily basis about seizures (severity, type), medications, and mood and stress levels. It also includes a camera-based application which uses a pill scanner and photo to record the identity and quantity (dose) of medications just prior to them being taken. Also included in the app are medication reminders, educational video clips, and self-management tips. |
|
| Telephone-based motivational interviewing (MORE+MI) | Behavioral | Participants will receive a total of 4 motivational interviewing sessions over the phone. These sessions last approximately 20 minutes each and build on the educational materials already provided within the MORE app. |
|
| Educational Materials | Other | Printed educational materials on the management of epilepsy |
|
| 3 months |
| Adherence to anti-epileptic drug schedule (self-reported) as measured by the Morisky Medication Adherence Scale | As measured by the Morisky Medication Adherence Scale | 3 months |
| Seizure frequency | 3 months |
| Quality of life as measured by the Quality of Life in Epilepsy questionnaire score | 3 months |
| Quality of life as measured by the PROMIS-10 questionnaire score | 3 months |